D-0299-2026 Class II Ongoing

Recalled by Greenstone Llc — Peapack, NJ

FDA drug recall D-0299-2026 was initiated by Greenstone Llc on Jan 15, 2026 and is designated Class II. Reason for recall: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. The recall status is ongoing. Affected quantity: 3456 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 4, 2026
Initiation Date
Jan 15, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3456 cartons

Product description

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2

Reason for recall

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Distribution pattern

Nationwide within the United States

Code information

Lot # LG7675, Exp. Date Nov 2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0299-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0299-2026. Report a data issue: hello@regdatalab.com.